Stock Fundamentals

Company Information

Company Name
Benitec Biopharma Ltd ADR
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US08205P2092
CIK: 0001808898
CUSIP: 08205P100
Currency: USD
Full Time Employees: 19
Phone: 510 780 0819
Fiscal Year End: June
IPO Date: Aug 18, 2015
Description:

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.

Address:

3940 Trust Way, Hayward, CA, United States, 94545

Directors & Officers

Name Title Year Born
Dr. Jerel A. Banks M.D., Ph.D. Executive Chairman & CEO 1976
Ms. Sophie Mukadam Chief Operating Officer 1981
Dr. Michael Graham Head of Discovery & Founding Scientist NA
Dr. Claudia Kloth Ph.D. Senior Vice President of Manufacturing NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 29, 2025 Suvretta Capital Management, L N/A Purchase 77.39K $13.44 $1.04M
Dec 26, 2025 Suvretta Capital Management, L N/A Purchase 16.84K $13.10 $220.55K
Dec 23, 2025 Suvretta Capital Management, L N/A Purchase 50.00K $12.85 $642.50K
Dec 22, 2025 Suvretta Capital Management, L N/A Purchase 19.54K $12.08 $236.07K
Dec 19, 2025 Suvretta Capital Management, L N/A Purchase 16.38K $11.48 $188.09K
Dec 18, 2025 Suvretta Capital Management, L N/A Purchase 10.22K $11.24 $114.82K
Nov 07, 2025 Suvretta Capital Management, L N/A Purchase 1.48M $13.50 $20.00M

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Suvretta Capital Management, LLC 11.55M Mar 31, 2026 33.62% $3.14 0.00%
HHG PLC 2.88M Mar 31, 2026 8.37% $0.01 -1.21%
Franklin Resources Inc 2.38M Mar 31, 2026 6.92% $0.01 8.23%
Adage Capital Partners Gp LLC 2.12M Mar 31, 2026 6.17% $0.03 0.00%
RA Capital Management, LLC 1.85M Mar 31, 2026 5.39% $0.21 0.00%
Nantahala Capital Management, LLC 1.44M Mar 31, 2026 4.19% $0.56 38.52%
BlackRock Inc 1.19M Mar 31, 2026 3.45% $0.00 19.49%
Vanguard Group Inc 1.17M Dec 31, 2025 3.42% $0.00 18.41%
Alyeska Investment Group, L.P. 750.00K Mar 31, 2026 2.18% $0.02 0.00%
SILVERARC CAPITAL MANAGEMENT, LLC 717.73K Mar 31, 2026 2.09% $0.78 -1.91%
Balyasny Asset Management LLC 653.84K Mar 31, 2026 1.90% $0.01 0.35%
Millennium Management LLC 652.06K Mar 31, 2026 1.90% $0.00 6.34%
Simplify Asset Management Inc. 562.24K Mar 31, 2026 1.64% $0.09 271.94%
Geode Capital Management, LLC 524.10K Mar 31, 2026 1.53% $0.00 15.60%
State Street Corp 338.25K Mar 31, 2026 0.98% $0.00 38.03%
Ameriprise Financial Inc 318.35K Mar 31, 2026 0.93% $0.00 13.40%
Longaeva Partners L.P. 290.00K Dec 31, 2025 0.84% $0.33 672.57%
MYDA Advisors LLC 225.00K Mar 31, 2026 0.65% $0.39 0.00%
The Goldman Sachs Group Inc 215.48K Mar 31, 2026 0.63% $0.00 23.81%
Awm Investment Company Inc 187.98K Mar 31, 2026 0.55% $0.22 -33.57%

Shares Statistics

Shares Outstanding: 34.35M
Shares Float: 17.87M
% Insiders: 269.90%
% Institutions: 9,825.40%
Short % Float: 11.60%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 HBM Healthcare Investments AG Ord 1.19M 3.47% ▲ 0.00% Mar 31, 2026
2 Franklin Biotechnology Discv A(acc)USD 997.48K 2.90% ▲ 0.00% Apr 30, 2026
3 Franklin Biotechnology Discovery A 995.15K 2.90% ▲ 0.00% Apr 30, 2026
4 Simplify Health Care ETF 652.69K 1.90% ▲ 0.00% Apr 30, 2026
5 Vanguard Total Stock Mkt Idx Inv 627.79K 1.83% ▲ 0.00% Apr 30, 2026
6 iShares Russell 2000 ETF 431.72K 1.26% ▲ 0.85% Apr 30, 2026
7 Janus Henderson Hrzn Biotec E2 USD 397.83K 1.16% ▼ 8.80% Mar 31, 2026
8 Franklin Small Cap Growth Adv 357.53K 1.04% ▲ 8.89% Apr 30, 2026
9 Franklin US Small Cap Growth Equity 328.33K 0.96% ▲ 0.00% Mar 31, 2026
10 Franklin Small Cap Growth SMA 328.33K 0.96% ▲ 5,472,066.67% Mar 31, 2026

Valuation Metrics

Enterprise Value: $189.89M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $363.47M
EBITDA: $-46.54M
PEG Ratio: $0.00
Book Value: $5.34
Earnings/Share: $-0.93
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -19.93%
ROE (TTM): -29.58%
Revenue (TTM): $7.00K
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 12.50%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-06-30 54.67x 0.00x 0.02x N/A -0.01x
2024-06-30 10.49x 0.01x 0.10x -24.88x -0.01x
2023-06-30 0.94x 1.36x 0.95x -578.21x -0.01x
2022-06-30 1.90x 0.09x 0.52x -557.94x -0.01x
2021-06-30 15.05x 0.01x 0.06x -2,266.00x -0.02x
2020-06-30 9.51x 0.02x 0.13x -133.56x -0.02x
2019-06-30 7.10x 0.00x 0.14x 15.17x 0.00x
2018-06-30 8.20x 0.00x 0.12x N/A 0.00x
2017-06-30 19.70x 0.00x 0.05x N/A 0.00x
2016-06-30 18.73x 0.00x 0.05x N/A 0.00x
2015-06-30 15.26x 0.00x 0.06x N/A 0.00x
2014-06-30 15.26x 0.00x 0.06x N/A 0.00x
2013-06-30 36.07x 0.00x 0.03x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about BNTC.US!